InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hopman Mark. Director active across 1 company, notably Beta Bionics, Inc.. Aggregated, 11 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €103k. History available since 27 February 2025. The latest transaction was disclosed on 4 June 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Hopman Mark is a declarant with 11 filings in total. Across the 11 sampled filings, which run from 2025-03-03 to 2026-06-25, the filings show disposals of EUR 103196, with Beta Bionics, Inc. as the company mentioned; the listed role for that company is Chief Commercial Officer.